Business Description
Lifeline Scientific Inc
NAICS : 334510
SIC : 3845
ISIN : USU529641008
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 186.85 | |||||
Equity-to-Asset | 0.87 | |||||
Interest Coverage | 184.36 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 8.55 | |||||
Beneish M-Score | -1.61 |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 10.7 | |||||
3-Year EBITDA Growth Rate | 109.5 | |||||
3-Year Book Growth Rate | 29.2 |
Momentum Rank
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.41 | |||||
Quick Ratio | 3.16 | |||||
Days Inventory | 136.9 | |||||
Days Sales Outstanding | 72.99 | |||||
Days Payable | 77.45 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.2 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 61.63 | |||||
Operating Margin % | 17.75 | |||||
Net Margin % | 32.74 | |||||
FCF Margin % | 15.3 | |||||
ROE % | 44 | |||||
ROA % | 37.04 | |||||
ROIC % | 52.62 | |||||
ROC (Joel Greenblatt) % | 53.85 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 6.57 | |||||
PE Ratio without NRI | 6.57 | |||||
Price-to-Owner-Earnings | 14.93 | |||||
PEG Ratio | 0.38 | |||||
PS Ratio | 2.37 | |||||
PB Ratio | 2.29 | |||||
Price-to-Free-Cash-Flow | 15.85 | |||||
Price-to-Operating-Cash-Flow | 11.4 | |||||
EV-to-EBIT | 10.65 | |||||
EV-to-EBITDA | 9.1 | |||||
EV-to-Revenue | 1.89 | |||||
Earnings Yield (Greenblatt) % | 9.39 | |||||
FCF Yield % | 7.38 | |||||
Forward Rate of Return (Yacktman) % | 17.48 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Lifeline Scientific Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil £) | 29.081 | ||
EPS (TTM) (£) | 0 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR (£) | 0 | ||
20-Day SMA (£) | 0 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (£) | 1.1 - 2.15 | ||
Shares Outstanding (Mil) | 19.45 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Lifeline Scientific Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Lifeline Scientific Inc Stock Events
Event | Date | Price(£) | ||
---|---|---|---|---|
No Event Data |
Lifeline Scientific Inc Frequently Asked Questions
What is Lifeline Scientific Inc(LSE:LSI)'s stock price today?
When is next earnings date of Lifeline Scientific Inc(LSE:LSI)?
Does Lifeline Scientific Inc(LSE:LSI) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |